Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-02

Clinical Trial Update: Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up

View source ↗

Summary

Observational long-term follow-up study of recovery from acute immune failure in septic shock treated with immune cell extracorporeal therapy; sponsor Artcline …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Immune cell extracorporeal therapy

Snippet

Sponsor: Artcline GmbH | Conditions: Severe Sepsis | Status: RECRUITING